BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 683308)

  • 1. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
    Nagy JI; Lee T; Seeman P; Fibiger HC
    Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors.
    Mishra RK; Wong YW; Varmuza SL; Tuff L
    Life Sci; 1978 Aug; 23(5):443-6. PubMed ID: 692267
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic and postsynaptic D1 dopamine receptors in the nigrostriatal system of the rat brain: a quantitative autoradiographic study using the selective D1 antagonist [3H]SCH 23390.
    Filloux FM; Wamsley JK; Dawson TM
    Brain Res; 1987 Apr; 408(1-2):205-9. PubMed ID: 2954613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations concerning the cellular origin of dopamine receptors.
    Henn FA; Titeler M; Anderson DJ; May K
    Life Sci; 1978 Aug; 23(6):617-21. PubMed ID: 692285
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 11. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease: low density and presynaptic location of D3 dopamine receptors.
    Lee T; Seeman P; Hornykiewicz O; Bilbao J; Deck J; Tourtellotte WW
    Brain Res; 1981 May; 212(2):494-8. PubMed ID: 7225883
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation by ATP of [3H]dopamine binding to synaptic membrane fractions of canine caudate nucleus.
    Sano K; Maeno H
    Biochem Biophys Res Commun; 1976 Dec; 73(3):584-90. PubMed ID: 1008875
    [No Abstract]   [Full Text] [Related]  

  • 15. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in dopamine receptors: effect of lesion and haloperidol treatment.
    Goldstein M; Lew JY; Asano T; Ueta K
    Commun Psychopharmacol; 1980; 4(1):21-5. PubMed ID: 6105037
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
    Murrin LC; Gale K; Kuhar MJ
    Eur J Pharmacol; 1979 Dec; 60(2-3):229-35. PubMed ID: 43260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low affinity, adenosine 5'-triphosphate-dependent [3H]dopamine binding in synaptic membranes from bovine caudate is unrelated to dopamine-stimulated adenylate cyclase.
    Near JA; Mahler HR
    J Neurosci; 1982 May; 2(5):553-61. PubMed ID: 6281399
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.
    Lee T; Seeman P; Tourtellotte WW; Farley IJ; Hornykeiwicz O
    Nature; 1978 Aug; 274(5674):897-900. PubMed ID: 683328
    [No Abstract]   [Full Text] [Related]  

  • 20. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
    Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
    Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.